The purpose of the test is to:
The Direct Coombs Test (DCT), also known as the Direct Antiglobulin Test (DAT), detects antibodies or complement proteins attached to the surface of red blood cells. These substances can cause red blood cells to be destroyed prematurely, a process known as hemolysis.
The test is commonly used when immune-mediated destruction of red blood cells is suspected. It can help evaluate conditions such as autoimmune hemolytic anemia, reactions following a blood transfusion, and certain cases of hemolytic disease in newborns.
A positive DCT does not by itself identify the exact cause of red blood cell destruction. The result is interpreted along with symptoms, blood counts, bilirubin, reticulocyte count, medical history, and other laboratory finding.
1. What does a Direct Coombs Test detect?
The DCT detects antibodies and/or complement attached to red blood cells. Their presence may indicate that the immune system is contributing to red blood cell destruction.
2. What does a positive Direct Coombs Test mean?
A positive result means antibodies or complement have been detected on the surface of red blood cells. It can occur in autoimmune hemolytic anemia, transfusion reactions, hemolytic disease of the newborn, and some medication-related conditions.
3. Is the Direct Coombs Test the same as the Indirect Coombs Test?
No. The Direct Coombs Test detects antibodies or complement already attached to red blood cells, while the Indirect Coombs Test detects antibodies circulating freely in the blood and is commonly used in blood compatibility testing and pregnancy-related screening.